Br Med J (Clin Res Ed)  1988;296:320-331 (30 January), doi:10.1136/bmj.296.6618.320

Secondary prevention of vascular disease by prolonged antiplatelet treatment

Antiplatelet Trialists' Collaboration

Thirty one randomised trials of antiplatelet treatment for patients with a history of transient ischaemic attack, occlusive stroke, unstable angina, or myocardial infarction were identified. Six were still in progress, and the results of the remaining 25 were reviewed. They included a total of some 29 000 patients, 3000 of whom had died. Overall, allocation to antiplatelet treatment had no apparent effect on non-vascular mortality but reduced vascular mortality by 15% (SD 4%) and non-fatal vascular events (stroke or myocardial infarction) by 30% (4%). This suggested that with good compliance these treatments might reduce vascular mortality by about one sixth, other vascular events by about a third, and total vascular events by about a quarter. There was no significant difference between the effects of the different types of antiplatelet treatment tested (300-325 mg aspirin daily, higher aspirin doses, sulphinpyrazone, or high dose aspirin with dipyridamole), nor between the effects in patients with histories of cerebral or cardiac disease. Thus antiplatelet treatment can reduce the incidence of serious vascular events by about a quarter among a wide range of patients at particular risk of occlusive vascular disease. The balance of risk and benefit, however, might be different for "primary" prevention among people at low absolute risk of occlusive disease if antiplatelet treatment produced even a small increase in the incidence of cerebral haemorrhage.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005
Tom Briffa, S Hickling, M Knuiman, M Hobbs, J Hung, F M Sanfilippo, K Jamrozik, and P L Thompson
BMJ 2009 338: b36. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Ross, J. S., Madigan, D., Hill, K. P., Egilman, D. S., Wang, Y., Krumholz, H. M. (2009). Pooled Analysis of Rofecoxib Placebo-Controlled Clinical Trial Data: Lessons for Postmarket Pharmaceutical Safety Surveillance. Arch Intern Med 169: 1976-1985 [Abstract] [Full text]  
  • Barnett, H. J.M. (2009). Personal Reflections From a Front-Row Seat at the Greatest Show on Earth (Life): Part II (Stroke Research Commentary). Stroke 40: e53-e65 [Full text]  
  • Briffa, T., Hickling, S, Knuiman, M, Hobbs, M, Hung, J, Sanfilippo, F M, Jamrozik, K, Thompson, P L (2009). Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005. BMJ 338: b36-b36 [Abstract] [Full text]  
  • Kiberd, B., Panek, R. (2008). Cardiovascular Outcomes in the Outpatient Kidney Transplant Clinic: The Framingham Risk Score Revisited. CJASN 3: 822-828 [Abstract] [Full text]  
  • O'Rourke, K. (2007). An historical perspective on meta-analysis: dealing quantitatively with varying study results. JRSM 100: 579-582 [Full text]  
  • Elwood, P. (2006). The first randomized trial of aspirin for heart attack and the advent of systematic overviews of trials. JRSM 99: 586-588 [Full text]  
  • Diener, H.-C. (2006). Update on clopidogrel and dual anti-platelet therapy: neurology. Eur Heart J Suppl 8: G15-G19 [Abstract] [Full text]  
  • Adesanya, A. O., de Lemos, J. A., Greilich, N. B., Whitten, C. W. (2006). Management of perioperative myocardial infarction in noncardiac surgical patients.. Chest 130: 584-596 [Abstract] [Full text]  
  • Eastaugh, J. L, Calvert, M. J, Freemantle, N. (2005). Highlighting the need for better patient care in stable angina: results of the international Angina Treatment Patterns (ATP) Survey in 7074 patients. Fam Pract 22: 43-50 [Abstract] [Full text]  
  • Shaya, F. T., Blume, S. W., Blanchette, C. M., Weir, M. R., Mullins, C. D. (2005). Selective Cyclooxygenase-2 Inhibition and Cardiovascular Effects: An Observational Study of a Medicaid Population. Arch Intern Med 165: 181-186 [Abstract] [Full text]  
  • Vilahur, G., Segales, E., Salas, E., Badimon, L. (2004). Effects of a Novel Platelet Nitric Oxide Donor (LA816), Aspirin, Clopidogrel, and Combined Therapy in Inhibiting Flow- and Lesion-Dependent Thrombosis in the Porcine Ex Vivo Model. Circulation 110: 1686-1693 [Abstract] [Full text]  
  • Warlow, C. (2004). The Willis Lecture 2003: Evaluating Treatments for Stroke Patients Too Slowly: Time to Get Out of Second Gear. Stroke 35: 2211-2219 [Full text]  
  • Berger, A. K., Duval, S., Krumholz, H. M. (2003). Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol 42: 201-208 [Abstract] [Full text]  
  • Johnsen, S. P., Pedersen, L., Friis, S., Blot, W. J., McLaughlin, J. K., Olsen, J. H., Sorensen, H. T. (2003). Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hospitalization for Intracerebral Hemorrhage: A Population-Based Case-Control Study. Stroke 34: 387-391 [Abstract] [Full text]  
  • Balk, E. M., Bonis, P. A. L., Moskowitz, H., Schmid, C. H., Ioannidis, J. P. A., Wang, C., Lau, J. (2002). Correlation of Quality Measures With Estimates of Treatment Effect in Meta-analyses of Randomized Controlled Trials. JAMA 287: 2973-2982 [Abstract] [Full text]  
  • Chalmers, I., Hedges, L. V., Cooper, H. (2002). A Brief History of Research Synthesis. Eval Health Prof 25: 12-37 [Abstract]  
  • Feldman, M., Cryer, B., Rushin, K., Betancourt, J. (2001). A Comparison of Every-Third-Day Versus Daily Low-Dose Aspirin Therapy on Serum Thromboxane Concentrations in Healthy Men and Women. CLIN APPL THROMB HEMOST 7: 53-57 [Abstract]  
  • Collinson, J, Flather, M.D, Fox, K.A.A, Findlay, I, Rodrigues, E, Dooley, P, Ludman, P, Adgey, J, Bowker, T.J, Mattu, R (2000). Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK). Eur Heart J 21: 1450-1457 [Abstract]  
  • Altman, R., Rouvier, J., Scazziota, A. (2000). State-of-the-Art Review : Secondary Prevention of Myocardial Infarction: Beneficial Effect of Combining Oral Anticoagulant Plus Aspirin: Therapy Based on Evidence. CLIN APPL THROMB HEMOST 6: 126-134  
  • ARDEKIAN, L., GASPAR, R., PELED, M., BRENER, B., LAUFER, D. (2000). DOES LOW-DOSE ASPIRIN THERAPY COMPLICATE ORAL SURGICAL PROCEDURES?. Journal of the American Dental Association 131: 331-335 [Abstract] [Full text]  
  • Smith, N. M, Pathansali, R., Bath, P. M. (1999). Platelets and stroke. Vasc Med 4: 165-172 [Abstract]  
  • Dangas, G., Badimon, J. J., Smith, D. A., Unger, A. H., Levine, D., Shao, J. H., Meraj, P., Fier, C., Fallon, J. T., Ambrose, J. A. (1999). Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile. J Am Coll Cardiol 33: 1294-1304 [Abstract] [Full text]  
  • O'Connor, G. T., Quinton, H. B., Traven, N. D., Ramunno, L. D., Dodds, T. A., Marciniak, T. A., Wennberg, J. E. (1999). Geographic Variation in the Treatment of Acute Myocardial Infarction: The Cooperative Cardiovascular Project. JAMA 281: 627-633 [Abstract] [Full text]  
  • Ramunno, L. D., Dodds, T. A., Traven, N. D. (1998). Cooperative Cardiovascular Project (CCP) Quality Improvement in Maine, New Hampshire, and Vermont. Eval Health Prof 21: 442-460 [Abstract]  
  • Saitta, A., Sardo, A., Bonaiuto, M., Giordano, G., Imbalzano, E., Castaldo, M., Cinquegrani, M., D'Arrigo, D., Campo, G. M., Squadrito, F. (1998). Effects of Picotamide on Release of Endothelin-1, Thromboxane, and Prostacycline After Treadmill Stress in Patients with Peripheral Artery Disease. ANGIOLOGY 49: 879-884 [Abstract]  
  • Wittwer, T., Wahlers, T., Dresler, C., Haverich, A. (1998). Carotid-Subclavian Bypass for Subclavian Artery Revascularization: Long-term Follow-up and Effect of Antiplatelet Therapy. ANGIOLOGY 49: 279-287 [Abstract]  
  • Altman, R. (1998). Controversies in Antithrombotic Therapy in Cardiovascular Diseases. CLIN APPL THROMB HEMOST 4: 11-24 [Abstract]  
  • Baker, W. F. JR (1998). Thrombosis and Hemostasis in Cardiology: Review of Pathophysiology and Clinical Practice (Part I). CLIN APPL THROMB HEMOST 4: 51-75 [Abstract]  
  • Schwartz, L. M., Fisher, E. S., Tosteson, A. N. A., Woloshin, S., Chang, C.-H., Virnig, B. A., Plohman, J., Wright, B. (1997). Treatment and Health Outcomes of Women and Men in a Cohort With Coronary Artery Disease. Arch Intern Med 157: 1545-1551 [Abstract]  
  • Hujoel, P.P., Leroux, B.G., DeRouen, T.A., Powell, L.V., Kiyak, H.A. (1997). Evaluating the Validity of Probing Attachment Loss as a Surrogate for Tooth Mortality in a Clinical Trial on the Elderly. JDR 76: 858-866 [Abstract]  
  • Deedwania, P. C., Amsterdam, E. A., Vagelos, R. H. (1997). Evidence-Based, Cost-effective Risk Stratification and Management After Myocardial Infarction. Arch Intern Med 157: 273-280 [Abstract]  
  • Savi, P., Heilmann, E., Nurden, P., Laplace, M.-C., Bihour, C., Kieffer, G., Nurden, A. T., Herbert, J.-M. (1996). Clopidogrel: An Antithrombotic Drug Acting on the ADP-dependent Activation Pathway of Human Platelets. CLIN APPL THROMB HEMOST 2: 35-42 [Abstract]  
  • Maruyama, S., Uchiyama, S., Tohgi, H., Hirai, S., Ikeda, Y., Shinohara, Y., Matsuda, T., Fujishima, M., Kameyama, M. (1995). A Randomized Trial of E5510 versus Aspirin in Patients with Transient Ischemic Attacks: The Japanese E5510 TIA Study-1 (JETS-1) Group. ANGIOLOGY 46: 999-1008 [Abstract]  
  • van Bergen, P. F. M. M., Jonker, J. J. C., van Hout, B. A., van Domburg, R. T., Deckers, J. W., Azar, A. J., Hofman, A. (1995). Costs and Effects of Long-term Oral Anticoagulant Treatment After Myocardial Infarction. JAMA 273: 925-928 [Abstract]  
  • Morris, C. R., Scheib, J. S. (1994). Fatal Myocardial Infarction Resulting From Coronary Arteritis in a Patient With Polymyalgia Rheumatica and Biopsy-Proved Temporal Arteritis: A Case Report and Review of the Literature. Arch Intern Med 154: 1158-1160 [Abstract]  
  • Woods, S. E. (1994). Primary Prevention of Coronary Heart Disease in Women: Should Asymptomatic Women 50 Years of Age Take Aspirin Regularly?. Arch Fam Med 3: 361-364 [Abstract]  
  • Neirotti, M., Molaschi, M., Ponzetto, M., Macchione, C., Poli, L., Bonino, F., Fabris, F. (1994). Hemodynamic, Hemorheologic, and Hemocoagulative Changes After Treatment With Picotamide in Patients Affected by Peripheral Arterial Disease (PAD) of the Lower Limbs. ANGIOLOGY 45: 137-141 [Abstract]  
  • Hennekens, C. H., Jonas, M. A., Buring, J. E. (1994). The Benefits of Aspirin in Acute Myocardial Infarction: Still a Well-Kept Secret in the United States. Arch Intern Med 154: 37-40 [Abstract]  
  • (1994). Aspirin to prevent heart attack or stroke. DTB 32: 1-3 [Abstract] [Full text]  
  • Anderson, D. C. (1993). How Twin Cities Neurologists Treat Ischemic Stroke: Policies and Trends. Arch Neurol 50: 1098-1103 [Abstract]  
  • Sivenius, J., Riekkinen, P. J., Lowenthal, A., Smets, P., Laakso, M. (1993). Antiplatelet Therapy Is Effective in Primary Prevention of Myocardial Infarction in Patients With a Previous Cerebrovascular Ischemic Event. Arch Neurol 50: 710-713 [Abstract]  
  • Kearon, C., Hirsh, J. (1993). Optimal Dose for Starting and Maintaining Low-Dose Aspirin. Arch Intern Med 153: 700-702 [Abstract]  
  • Cleophas, T. J. M., Tavenier, P., Niemeyer, M. G. (1993). The Risk of Emergency Intestinal Bleeding Among Users of Acenocoumarin: A Population-Based Cohort Study. ANGIOLOGY 44: 85-92 [Abstract]  
  • (1992). Special Resuscitation Situations. JAMA 268: 2242-2250 [Abstract]  
  • ETDRS Investigators, , Kassoff, A., Buzney, S. M., McMeel, J. W., Weiter, J. J., Doyle, G. J., Immerman, R. L., Friedman, G. R., Klein, M. L., Dreyer, R., Chenoweth, R., Handelman, I., Hohl, R., Biesbroeck, R., Sipperley, J., Garcia, C. A., Bloome, M. A., Ruiz, R. S., Riekhof, F. T., Bohart, W. A., Goodart, R. A., Clarke, D. H., Orth, D. H., Flood, T. P., Packo, K. H., Malhotra, J., Rahmani, A., Winter, E. J., Bhatia, H., Murphy, R. P., Fine, S. L., Elman, M. J., Ferris, F. L. III, Prout, T. E., Patz, A., Rice, T. A., Newsome, D., Aiello, L. M., Rand, L. I., Shah, S. T., Cooppan, R., Cavallerano, J., Poole, R., Silver, P., Briones, J. Jr, Wafai, M. Z., Asmal, A. C., Franklin, R. M., Arend, L., Bergsma, D., Turkish, L., Beer, P., Carroll, D., Thomas, E., Burton, T. C., Abrams, G. W., Kim, H.-J., Williams, G. A., Topping, T. M., Reeser, F. H., Aaberg, T. M., Brinton, G. S., Kingham, J. K., Meredith, T. A., Margherio, R. R., Murphy, P. L., Cox, M. S., Trese, M., Winokur, S., Ai, E., Sorenson, R., Arsham, G., Cavender, J., Kopelow, S. M., Shabo, A. L., Briones, J. C. Jr, Hornichter, R. D., Blair, N. P., Goldberg, M. F., Lindberg, C. R., Ross, N. L., Hauser, L. E., Cunha-Vaz, J., Ernest, J. T., Liang, J. C., Cohen, S. B., Vygantas, C., Williams, G., Flynn, H. W. Jr, Blankenship, G. W., Knobloch, W. H., Ramsay, R. C., Cantrill, H. L., Goetz, F. C., Hoogwerf, B., Berrocal, J., Perez, R., Umpierre, A. R., Kinyoun, J. L., Kalina, R. E., Wells, C. G., Guzak, S. V., Palmer, J., Myers, F. L., Bresnick, G. H., Chandra, S. R., Davis, M. D., Klein, R., Stevens, T. S., Wallow, I. H., Dixon, R., Ehrlich, E., Ewart, R., Frank, R. N., Lucas, S., Whitehouse, F., Weiss, H., Ballen, A. E., Teske, M., Warth, M., Benson, W. E., Tasman, W. S., Brown, G. C., McNamara, J. A., Little, H. L., Jack, R. L., Basso, L., Miller, D. T., Gunter, E., Bayse, D. D., Hannon, W. H., Myrick, J. E., Knatterud, G. L., Fisher, M. R., Prior, M. J., Barton, F., Kufera, J., Miller, T. W., Hooper, J. K., Crow, R. S., Baker, R. R., Prineas, R., Davis, M. D., Hubbard, L. D., Magli, Y. L., Segal, P., Ferris, F. L. III, Mowery, R. L., Chew, E. Y., Seigel, D. G., Cassel, G. (1992). Aspirin Effects on Mortality and Morbidity in Patients With Diabetes Mellitus: Early Treatment Diabetic Retinopathy Study Report 14. JAMA 268: 1292-1300 [Abstract]  
  • Antman, E. M., Lau, J., Kupelnick, B., Mosteller, F., Chalmers, T. C. (1992). A Comparison of Results of Meta-analyses of Randomized Control Trials and Recommendations of Clinical Experts: Treatments for Myocardial Infarction. JAMA 268: 240-248 [Abstract]  
  • Haynes, R. B., Sandler, R. S., Larson, E. B., Pater, J. L., Yatsu, F. M. (1992). A Critical Appraisal of Ticlopidine, a New Antiplatelet Agent: Effectiveness and Clinical Indications for Prophylaxis of Atherosclerotic Events. Arch Intern Med 152: 1376-1380 [Abstract]  
  • Fugger, R., Prager, M., Sautner, T., Magometschnigg, H., Kretschmer, G., Polterauer, P. (1992). Ten Years of Experience with Aortoiliac Polytetrafluoroethylene Grafts--Effects of Postoperative Anticoagulation on Graft Function and Patient Survival. VASC ENDOVASCULAR SURG 26: 265-271 [Abstract]  
  • Harker, L. A., Bernstein, E. F., Dilley, R. B., Scala, T. E., Sise, M. J., Hye, R. J., Otis, S. M., Roberts, R. S., Michael, G. (1992). Failure of Aspirin plus Dipyridamole To Prevent Restenosis after Carotid Endarterectomy. ANN INTERN MED 116: 731-736 [Abstract]  
  • D'Agostino, R. B., Cobb, J. L., Wolf, P. A., Wilson, P. W. F. (1992). Aspirin Use and Cardiovascular Disease in Women. JAMA 267: 364-365 [Abstract]  
  • Grundy, S. M., Vega, G. L. (1992). Two Different Views of the Relationship of Hypertriglyceridemia to Coronary Heart Disease: Implications for Treatment. Arch Intern Med 152: 28-34 [Abstract]  
  • Mayberg, M. R., Wilson, S. E., Yatsu, F., Weiss, D. G., Messina, L., Hershey, L. A., Colling, C., Eskridge, J., Deykin, D., Winn, H. R., Veterans Affairs Cooperative Studies Program 309 T, , Kistler, P., Mohr, P.J., Kontos, H., Winn, H. R., Mayberg, M. R., Wilson, S. E., Yatsu, F., Weiss, D. G., Hershey, L. A., Messina, L., Winn, H. R., Colling, C., Platt, M., Ernst, C., Wechsler, L., Hall, E., Weiss, M., Kurz, R., Perez, E., Safer, D., Moore, R. M., Hobbins, T., Arthur, M., Raskin, A., Feldbush, R. M., Lee, M., Preston, D., Davis, D., Dunford, L., Lucas, C., Eskridge, J., Colling, C., Bergan, J., Dacey, R. G. Jr, Grotta, J., Barnett, H. J. M., Bergan, J., Heros, R., Mohr, J. P., Moore, W. S., Deykin, D., Gold, J., Huang, P., Messina, L., Fink, D., Chimowitz, M., McGillicuddy, J., Grube, S., Morgenstern, E., Rerych, S., McCutcheon, C., Ammons, J., Smith, R., Giannetti, R., Johnson, W., Babikian, V., Abramovitz, J., Allen, N., Hershey, L., Gutierrez, I., Corbett, V., Barren, J., Padberg, F. Jr., Shanawani, S., Rogers, C., Reid, S., Nadeau, S., Seeger, J., Baum, R., Littooy, F., Gupta, S., Maggio, J., Lalka, S., Reddy, R. V., Kriese, M., Acher, C., Levine, R., Archibald, J., Strawn, D., Remler, M., Calogero, D., Lawrence, W., Cintera, I., Hall, M., Jones, D., Makaroun, M., Thompson, J., Faris, A., Moossv, J., Love, S., Lyden, P., Hye, R., Lamond, R., Babcock, T., Cali, G., Bird, T., Emmons, F., Ploch, N., Cohen, S., Williams, R., Frazee, J., Josephson, M., Hubbert, C. (1991). Carotid Endarterectomy and Prevention of Cerebral Ischemia in Symptomatic Carotid Stenosis. JAMA 266: 3289-3294 [Abstract]  
  • Rothrock, J. F., Hart, R. G. (1991). Antithrombotic Therapy in Cerebrovascular Disease. ANN INTERN MED 115: 885-895 [Abstract]  
  • Manson, J. E., Stampfer, M. J., Colditz, G. A., Willett, W. C., Rosner, B., Speizer, F. E., Hennekens, C. H. (1991). A Prospective Study of Aspirin Use and Primary Prevention of Cardiovascular Disease in Women. JAMA 266: 521-527 [Abstract]  
  • Appel, L. J., Bush, T. (1991). Preventing Heart Disease in Women: Another Role for Aspirin?. JAMA 266: 565-566 [Abstract]  
  • The Asymptomatic Cervical Bruit Study Group, (1991). Natural History and Effectiveness of Aspirin in Asymptomatic Patients With Cervical Bruits. Arch Neurol 48: 683-686 [Abstract]  
  • Grotta, J. C (1991). Prevention and management of stroke. Vasc Med 2: 3-17  
  • Hamsten, A. (1991). Myocardial infarction at a young age: mechanisms and management. Vasc Med 2: 45-60  
  • Becker, R. C., Alpert, J. S. (1990). The Impact of Medical Therapy on Hemorrhagic Complications Following Coronary Artery Bypass Grafting. Arch Intern Med 150: 2016-2021 [Abstract]  
  • Aspey, B., Harrison, M. (1990). Sex differences in the antithrombotic effectiveness of aspirin. Vasc Med 1: 113-119  
  • M., C. (1990). How to Perform a Meta-Analysis. Science 249: 477-477  
  • Clagett, G. P. (1990). Antithrombotic Drugs and Vascular Surgery. PERSPECT VASC SURG ENDOVASC THER 3: 79-102  
  • Cebul, R. D., Whisnant, J. P. (1989). Carotid Endarterectomy. ANN INTERN MED 111: 660-670 [Abstract]  
  • Harris, E. J. JR, Porter, J. M. (1989). Thrombolytic Therapy and Modern Vascular Surgery: An Overview. PERSPECT VASC SURG ENDOVASC THER 2: 40-63  
  • Yusuf, S., Wittes, J., Friedman, L. (1988). Overview of Results of Randomized Clinical Trials in Heart Disease: I. Treatments Following Myocardial Infarction. JAMA 260: 2088-2093 [Abstract]  
  • MacMahon, S., Collins, R., Peto, R., Koster, R. W., Yusuf, S. (1988). Effects of Prophylactic Lidocaine in Suspected Acute Myocardial Infarction: An Overview of Results From the Randomized, Controlled Trials. JAMA 260: 1910-1916 [Abstract]  
  • Young, F. E., Nightingale, S. L., Temple, R. A. (1988). The Preliminary Report of the Findings of the Aspirin Component of the Ongoing Physicians' Health Study: The FDA Perspective on Aspirin for the Primary Prevention of Myocardial Infarction. JAMA 259: 3158-3160 [Abstract]  
Access jobs at BMJ Careers
Whats new online at Student BMJ